Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
4(15%)
Results Posted
9%(1 trials)
Terminated
2(8%)

Phase Distribution

Ph phase_2
2
8%
Ph phase_3
4
15%
Ph not_applicable
12
46%
Ph phase_4
4
15%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution22 total trials
Phase 2Efficacy & side effects
2(9.1%)
Phase 3Large-scale testing
4(18.2%)
Phase 4Post-market surveillance
4(18.2%)
N/ANon-phased studies
12(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

4

trials recruiting

Total Trials

26

all time

Status Distribution
Active(5)
Completed(11)
Terminated(3)
Other(7)

Detailed Status

Completed11
unknown7
Active, not recruiting2
Terminated2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
4
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (9.1%)
Phase 34 (18.2%)
Phase 44 (18.2%)
N/A12 (54.5%)

Trials by Status

withdrawn14%
active_not_recruiting28%
completed1142%
not_yet_recruiting14%
terminated28%
unknown727%
recruiting28%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT07442500

Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease

Not Yet Recruiting
NCT03381872Not Applicable

Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease

Active Not Recruiting
NCT05305482Not Applicable

DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial

Recruiting
NCT05493904Not Applicable

PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)

Active Not Recruiting
NCT06104033

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Recruiting
NCT06084000Not Applicable

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

Unknown
NCT05680051Not Applicable

DCB Under the Guidance of OCT in STEMI

Unknown
NCT05575245Not Applicable

Clinical Of Drug-eluting Stent Versus Excimer Laser Ablation Combined Drug-coated Balloon To Treat Arteriosclerosis Occlusive Disease Of Lower Extremity

Withdrawn
NCT01121224Phase 4

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty

Completed
NCT04778969

Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database

Unknown
NCT04744571Not Applicable

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Unknown
NCT01879358Not Applicable

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

Unknown
NCT02328781Not Applicable

Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System

Completed
NCT04072081Not Applicable

Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions

Unknown
NCT03899818Not Applicable

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment

Completed
NCT03671655Not Applicable

Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents

Terminated
NCT03452904Phase 3

FrActional Flow Reserve Guided Drug Coated Balloon Only Strategy in De Novo coronarY Lesions (FADDY)

Unknown
NCT00713557

Shanghai Registry of Acute Coronary Events

Terminated
NCT00323895Phase 4

The Intra-Drug Eluting Stent (DES) Restenosis Study

Completed
NCT00232869Phase 2

A Study of the SMART Stent in the Treatment SFA Disease.

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
26